Your browser doesn't support javascript.
loading
Camrelizumab plus oxaliplatin-based chemotherapy as first-line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial.
Chen, Xinni; Qin, Shukui; Gu, Shanzhi; Ren, Zhenggang; Chen, Zhendong; Xiong, Jianping; Liu, Ying; Meng, Zhiqiang; Zhang, Xiao; Wang, Linna; Zhang, Xiaojing; Zou, Jianjun.
Afiliação
  • Chen X; Department of Medical Oncology Center, Bayi Affiliated Hospital, Nanjing University of Chinese Medicine, Nanjing, China.
  • Qin S; Department of Medical Oncology Center, Bayi Affiliated Hospital, Nanjing University of Chinese Medicine, Nanjing, China.
  • Gu S; Department of Interventional Radiology, Hunan Cancer Hospital, Changsha, China.
  • Ren Z; Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Chen Z; Department of Medical Oncology, The Second Hospital of Anhui Medical University, Hefei, China.
  • Xiong J; Department of Medical Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Liu Y; Department of Medical Oncology, Henan Cancer Hospital, Zhengzhou, China.
  • Meng Z; Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhang X; Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
  • Wang L; Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
  • Zhang X; Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
  • Zou J; Jiangsu Hengrui Pharmaceuticals Co., Ltd, Shanghai, China.
Int J Cancer ; 149(11): 1944-1954, 2021 12 01.
Article em En | MEDLINE | ID: mdl-34309846

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Oxaliplatina Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Oxaliplatina Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China